What's breaking now, across thousands of outlets.
A gene responsible for compacting trash inside the brain appears to be a key player in Alzheimer's disease, and doctors may be able to target it to better treat or help prevent the devastating condition, new UVA Health research suggests.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link to permanent vision loss , the US Food and Drug Administration has said. The regulator said that it based the decision on research that linked a rare eye condition, called non-arteritic anterior ischemic optic…
The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link to permanent vision loss , the US Food and Drug Administration has said. The regulator said that it based the decision on research that linked a rare eye condition, called non-arteritic anterior ischemic optic…
A look at 15 U.S. vaccine makers and global drugmakers behind shots for flu, COVID-19, shingles and HPV, and the products each company is known for
A new study reveals how the hormone oxytocin alters the brain's ability to learn and remember social hierarchies, boosting memory for networks that do not directly involve the observer.
Australian developer Currus Bio predicts that automating the production of its candidate cancer cell therapy, CUR-001, using the Cocoon platform will reduce costs and enhance its ability to scale…
A company developing extracellular vesicle-based products has developed a potency assay for quality control. They hope to adapt it for future products and scale it to commercial manufacturing. The post Extracellular Vesicle Product Developer Creates Potency Assay appeared first on GEN - Genetic Engineering and Biotechnology News .
